|
|
| Model Number |
SCPX117MH |
| Medical Device Problem Code |
Material Rupture (1546)
|
| Health Effect - Clinical Code |
Deformity/ Disfigurement (2360)
|
| Date of Event |
04/03/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a 41-year-old caucasian female who underwent breast augmentation with a 350cc mentor cpx4 plus smooth medium height tissue expander experienced left sided deflation post procedure.The deflation was diagnosed through a physical examination.As a result, replacement with a new mentor tissue expander was performed on (b)(6) 2023.
|
| |
|
Additional Manufacturer Narrative
|
|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: deflation mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.If certain information is unknown, not available or does not apply, the section/field of the form is left blank.Manufacturer¿s reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The mentor failure analysis lab has received the device for evaluation.The analysis has begun but is not complete at this time.When the investigation and analysis have been completed, a supplemental report will be submitted.Manufacturer¿s reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The investigation of the returned device was completed by the failure analysis lab on august 17, 2023.Device evaluation summary: the product was returned to mentor for evaluation.Mentor then conducted a visual inspection and leak testing of the returned device.During the visual analysis of the returned sample, a delamination was observed at the injection dome.Leak testing was performed, in accordance with mentor procedures, and a leak was observed caused by the delamination at the injection dome.Based on the information currently available, a product issue was identified during the investigation of the product received.This product issue will be addressed through the mentor¿s quality system.According to the manufacturing investigation, in conclusion, with consideration to the process controls, the evaluation performed by the complaint handling team, and data records reviewed for the complaint device, the delamination reported on the product complaint is not able to be confirmed as a manufacturing defect.As part of mentor¿s quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Manufacturer¿s reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The device evaluation summary was updated by the failure analysis lab on september 21, 2023.Updated device evaluation summary: the product was returned to mentor for evaluation.Mentor then conducted a visual inspection and leak testing of the returned device.During the visual analysis of the returned sample, a delamination was observed between the bladder and the injection dome.Leak testing was performed, in accordance with mentor procedures, and a leak was observed caused by the delamination between the bladder and the injection dome.Based on the information currently available, a product issue was identified during the investigation of the product received.This product issue will be addressed through the mentor¿s quality system.According to the manufacturing investigation, fourier transform infrared spectroscopy (ftir) was performed to evaluate if poly sheeting presence was contributing to the root cause of the delamination in the injection dome assembly of the returned devices, as a result of the analysis no poly sheeting was found.In conclusion, with consideration of the process controls, the evaluation performed by the complaint handling team, the data records reviewed, and the fourier transform infrared spectroscopy (ftir) for the complaint device, the delamination reported on the product complaints is not able to be confirmed as a manufacturing defect.The cause of the delamination could not be confirmed.As part of mentor¿s quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Manufacturer¿s reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|